Zusammenfassung
Systematische Analysen zur Gen- und Proteinexpression bei Speicheldrüsentumoren sind Voraussetzung für die Identifizierung tumorassoziierter Gene. Aus dem Hamburger Speicheldrüsenregister standen Proben in ausreichender Menge und Vielfalt zur Verfügung, sodass Gewebemikroarrays („tissue micro-array“/TMA) hergestellt werden konnten. Ziel war es, zu untersuchen, inwieweit TMA für die Speicheldrüsentumordiagnostik und -forschung einsetzbar sind. In der Studie wurden überwiegend Antikörper eingesetzt, die auch routinemäßig zur Absicherung der Diagnose verwendet werden.
Epitheliale Marker ließen keine tumortypspezifische Charakterisierung zu. Myoepitheliale Marker eigneten sich dagegen zur Abgrenzung biphasischer Tumoren von rein epithelialen Tumoren. Der Amylasenachweis in Azinuszellkarzinomen sowie der Nachweis von Steroidrezeptoren in diesen und anderen Speicheldrüsentumoren haben in Verbindung mit der Expression von Transkriptionsfaktoren, Tumormarkern und der Proliferationsrate bei malignen Speicheldrüsentumoren Expressionsprofile ergeben, die diagnostisch und klinisch relevant sein können und/oder eine Grundlage für weiterführende, insbesondere molekulare Untersuchungen sind.
Abstract
Systematic analysis of gene expression in salivary gland tumors is necessary to identify genes associated with specific tumor types. From the salivary gland register of the University Hospital Hamburg-Eppendorf sufficient samples of various tumors were available to generate Tissue Micro-Arrays (TMA). In light of the considerable heterogeneity of salivary gland tumors, this study was aimed at evaluating the suitability of TMA in salivary gland diagnostics and research.
Epithelial antigens are not sufficient for a tumortype-specific characterization. Myoepithelial markers are suitable for distinguishing biphasic tumor types from purely epithelial tumors. The detection of amylase in acinic cell carcinomas, and the detection of steroid hormone receptors in these and other malignant salivary gland tumors particularly in combination with the expression of transcription factors, oncogenes and proliferation associated antigens result in characteristic expression profiles. These may prove to be valuable for further investigations, especially on the molecular level.
Literatur
Aigner T, Neureiter D, Völker U et al. (1998) Epithelial-mesenchymal transdifferentiation and extracellular matrix gene expression in pleomorphic adenomas of the parotid salivary gland. J Pathol 186:178–185
Astrom AK, Voz ML, Kas K et al. (1999) Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res 59:918–923
Auclair PL, Ellis GL, Gnepp DR et al. (1991) Salivary gland neoplasms: general considerations. In: Ellis GL, Auclair PL, Gnepp DR (eds) Surgical pathology of the salivary glands. WB Saunders, Philadelphia, pp 135–164
Boonyaratanakornkit V, Melvin V, Prendergast P et al. (1998) High-mobility group chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Mol Cell Biol 18:4471–4487
Chen B, van den Brekel MW, Buschers W et al. (2003) Validation of tissue array technology in head and neck squamous cell carcinoma. Head Neck 25:922–930
Eneroth CM (1971) Salivary gland tumors in the parotid gland, submandibular gland, and the palate region. Cancer 27:1415–1418
Eveson JW, Cawson RA (1985 a) Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol 146:51–58
Eveson JW, Cawson RA (1985 b) Tumours of the minor (oropharyngeal) salivary glands: a demographic study of 336 cases. J Oral Pathol 14:500–509
Foote FW Jr, Frazell EL (1953) Tumors of the major salivary glands. Cancer 6:1065–1133
Geurts JM, Schoenmakers EF, Roijer E et al. (1998) Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas. Oncogene 16:865–872
Hoos A, Urist MJ, Stojadinovic A et al. (2001) Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 158:1245–1251
Iwafuchi H, Mori N, Takahashi T, Yatabe Y (2004) Phenotypic composition of salivary gland tumors: an application of principle component analysis to tissue microarray data. Mod Pathol 17:803–810
Kas K, Voz ML, Roijer E et al. (1997) Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations [published erratum appears in Nat Genet 1997 15:411]. Nat Genet 15:170–174
Milanes-Yearsley M, Hammond ME, Pajak TF et al. (2002) Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Mod Pathol 15:1366–1373
Onate SA, Prendergast P, Wagner JP et al. (1994) The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol Cell Biol 14:3376–3391
Packeisen J, Korsching E, Herbst H et al. (2003) Demystified ... tissue microarray technology. Mol Pathol 56:198–204
Romine LE, Wood JR, Lamia LA et al. (1998) The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol 12:664–674
Schraml P, Kononen J, Bubendorf L et al. (1999) Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5:1966–1975
Schraml P, Schwerdtfeger G, Burkhalter F et al. (2003) Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol 163:985–992
Seifert G, Miehlke A, Haubrich J, Chilla R (1986) Diseases of the salivary glands: pathology — diagnosis — treatment — facial nerve surgery. Thieme, Stuttgart, pp 182–193
Soini Y, Kamel D, Nuorva K et al. (1992) Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch A Pathol Anat Histopathol 421:415–420
Verrier CS, Roodi N, Yee CJ et al. (1997) High-mobility group (HMG) protein HMG-1 and TATA-binding protein-associated factor TAF(II)30 affect estrogen receptor-mediated transcriptional activation. Mol Endocrinol 11:1009–1019
Zarbo RJ (2002) Salivary gland neoplasia: a review for the practicing pathologist. Mod Pathol 15:298–323
Danksagung
Die Arbeiten wurden durch Zuwendungen der Hamburger Stiftung zur Förderung der Krebsbekämpfung (157), der Deutschen Forschungsgemeinschaft (RO 2081/1) und der Medizinischen Fakultät Münster (IMF HU120115) gefördert.
Interessenkonflikt:
Keine Angaben
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Röser, K., Jäkel, K.T., Herbst, H. et al. Immunphänotypische Charakterisierung von Speicheldrüsentumoren unter Verwendung von Gewebe-Micro-Arrays. Pathologe 26, 345–352 (2005). https://doi.org/10.1007/s00292-005-0777-y
Issue Date:
DOI: https://doi.org/10.1007/s00292-005-0777-y